Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review
Mohammad Saied Salehi, Benjamin Jurek, Saeideh Karimi‐Haghighi, Nahid Jashire Nezhad, Seyedeh Maryam Mousavi, Etrat Hooshmandi, Anahid Safari, Mehdi Dianatpour, Silke Haerteis, Jaleel A. Miyan, Sareh Pandamooz, Afshin Borhani‐Haghighi
Abstract
Abstract Intranasal delivery of stem cells and conditioned medium to target the brain has attracted major interest in the field of regenerative medicine. In pre-clinical investigations during the last ten years, several research groups focused on this strategy to treat cerebral hypoxia/ischemia in neonates as well as adults. In this review, we discuss the curative potential of stem cells, stem cell derivatives, and their delivery route via intranasal application to the hypoxic/ischemic brain. After intranasal application, stem cells migrate from the nasal cavity to the injured area and exert therapeutic effects by reducing brain tissue loss, enhancing endogenous neurogenesis, and modulating cerebral inflammation that leads to functional improvements. However, application of this administration route for delivering stem cells and/or therapeutic substances to the damaged sites requires further optimization to translate the findings of animal experiments to clinical trials.